/stocks — the workspaceLOADING
Caris Life Sciences, Inc. (CAI) is a services-medical laboratories company. Piotroski F-Score 5/8. 9 insider Form 4 filings in the last 90 days. Fundamentals from SEC filings; prices are end-of-day.
EOD daily bars · delayed, not real-time · data: DatabentoCharting by TradingView Lightweight Charts™
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
FY ending 2025-12-31 vs 2024-12-31. original 1968 formula; calibrated on manufacturers, read financials/REITs with care
A plain-English read on CAI plus an auto-SWOT — built from CAI's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate CAI using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
| Duquesne Family Office (Druckenmiller) | $34K | 1.0% of portfolio |
Projected from CAI's own SEC 8-K filing history — the year-over-year reporting pattern (~50% land the exact day, ~90% within a week). No analyst estimates, no scraped calendars, nothing invented. It upgrades to a confirmed date + time the moment CAI files its announcement.
CAI has sold off after 3 of its last 5 earnings reports.
Large earnings reactions have been common.
CAI has traded lower after most recent earnings releases.
A more typical earnings reaction has been approximately ±13.5%.
Realized close-to-close history only — no options-implied move, no analyst estimates.
| Reported | Close-to-close |
|---|---|
| 2026-05-07 | -15.6% |
| 2026-02-26 | +10.0% |
| 2026-01-12 | -7.4% |
| 2025-11-05 | -21.1% |
| 2025-08-12 | +13.5% |
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
| HALBERT JONDirector | BUY | $990K | view → |
| Vacirca Jeff LDirector | BUY | $501K | view → |